Vyera Pharmaceuticals

New York, United States Founded: 2008 • Age: 18 yrs
Delivers comprehensive small molecule therapeutics for toxoplasmosis and neglected parasitic infections.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Vyera Pharmaceuticals

Vyera Pharmaceuticals is a company based in New York (United States) founded in 2008. It operates as a B2B. Vyera Pharmaceuticals operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Vyera Pharmaceuticals

Headcount 50-200
Employee Profiles 3
Employee Profiles
People
Averill Powers
Chief Strategy Officer And General Counsel
People
Melissa G.
Manager

Unlock access to complete

Funding Insights of Vyera Pharmaceuticals

Premium access

Detailed funding history for Vyera Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Vyera Pharmaceuticals

Investments
Premium access

Investment portfolio details for Vyera Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Vyera Pharmaceuticals

Premium access

Detailed financials for Vyera Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Vyera Pharmaceuticals Comparisons

Vyera Pharmaceuticals Primary company
Description
Delivers comprehensive small molecule therapeutics for toxop...
Location
New York, United States
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Vyera Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Vyera Pharmaceuticals

Vyera Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
An AI-enabled platform is developed for infectious disease treatment.
Locked Locked Locked
Therapeutics for genetic diseases are developed through targeted interventions.
Locked Locked Locked
A biopharmaceutical company accelerating innovative mental health treatments.
Locked Locked Locked
Gene therapies for rare diseases are developed to treat patients.
Locked Locked Locked
Gene therapies for rare diseases including retinal dystrophies are developed.
Locked Locked Locked
Provider of cell therapies to treat cancer and hematologic conditions
Premium access

Detailed competitors of Vyera Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Vyera Pharmaceuticals

Premium access

Complete news archive for Vyera Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vyera Pharmaceuticals

Vyera Pharmaceuticals was founded in 2008.

Vyera Pharmaceuticals is headquartered in New York, United States. It is registered at New York, New York, United States.

Vyera Pharmaceuticals, established in 2008, excels in providing healthcare solutions, producing pharmaceutical products, therapeutics, and parasitic infections. Delivers comprehensive small molecule therapeutics for toxoplasmosis and neglected parasitic infections. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Vyera Pharmaceuticals's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available